Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence"

Head Neck. 2015 Aug;37(8):1137-41. doi: 10.1002/hed.23715. Epub 2014 Jul 11.

Abstract

Background: The registry for the evaluation of side effects after radiotherapy in childhood and adolescence (RiSK) was established to prospectively characterize radiation-associated side effects. The purpose of this analysis was to characterize side effects after radiotherapy to the head and neck in children and adolescents.

Methods: Radiation doses have been collected across Germany since 2001. Acute and late side effects were characterized.

Results: Until January 2010, 133 patients (median age, 12.7 years) were recruited who had received radiotherapy to the salivary glands. Toxicity evaluation was available for 114 patients (median follow-up, 2.9 years). Acute and late toxicity significantly depended on the maximum radiation dose to the salivary glands. An increase of the mean value of maximum dose of 1 Gray (Gy) to the submandibular glands resulted in an odds ratio of 1.04 (range, 1.00-1.08; p = .039) for acute toxicities of the salivary glands and 1.08 (range, 1.03-1.13; p = .001) for acute mucosal toxicities.

Conclusion: These data can be used for an individual risk assessment in pediatric head and neck radiotherapy.

Keywords: adolescence; childhood; head and neck; radiation; salivary gland.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Radiation*
  • Female
  • Follow-Up Studies
  • Germany / epidemiology
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Infant
  • Male
  • Mouth Mucosa / radiation effects*
  • Prospective Studies
  • Radiation Injuries / epidemiology
  • Radiation Injuries / etiology*
  • Radiopharmaceuticals
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant / adverse effects*
  • Registries
  • Risk Assessment
  • Risk Factors
  • Salivary Glands / radiation effects*
  • Time Factors

Substances

  • Radiopharmaceuticals